Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
5.17M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
830K
-
Shares change
-
-301K
-
Total reported value, excl. options
-
$7.33M
-
Value change
-
-$3.25M
-
Number of buys
-
2
-
Number of sells
-
-6
-
Price
-
$10.86
Significant Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) as of Q3 2023
15 filings reported holding CERO - CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share as of Q3 2023.
CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 830K shares
of 5.17M outstanding shares and own 16.06% of the company stock.
Largest 10 shareholders include METEORA CAPITAL, LLC (170K shares), CANTOR FITZGERALD, L. P. (155K shares), Mint Tower Capital Management B.V. (141K shares), Yakira Capital Management, Inc. (108K shares), CLEAR STREET LLC (73.4K shares), Shaolin Capital Management LLC (50K shares), Walleye Capital LLC (47.9K shares), BERKLEY W R CORP (47.2K shares), Walleye Trading LLC (27K shares), and GEODE CAPITAL MANAGEMENT, LLC (10.6K shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.